Pulmonary Healthy Controls, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Non-specific Interstitial Pneumonia, Sarcoidosis, Granulomatosis With Polyangiitis (Wegener's Disease)
Conditions
Brief summary
Current diagnostic tools used in interstitial lung disease (ILD) do not meet the challenges set by the complex pathophysiology of this heterogenous group. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and therapeutic monitoring of patients with various ILDs.
Interventions
Sponsors
Universitätsmedizin Mannheim
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* known or suspected interstitial lung disease
Exclusion criteria
* pregnancy * inability to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lung clearance index (LCI) as determined by multiple breath washout | 30 minutes |
| airway resistance and reactance (R5, X5, R-D5-20) as determined by impulse oscillometry | 30 minutes |
Secondary
| Measure | Time frame |
|---|---|
| repeatability of lung clearance index (LCI) | 30 minutes |
Countries
Germany
Contacts
Primary ContactFrederik Trinkmann, Dr.
Outcome results
None listed